Search
PolyPid Ltd
PYPDAdd to Watchlist
5.020USD
-0.030-0.59%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
91.38MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
4
analysts
Buy
Current Rating
12.250
Target Price
+146.48%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
PolyPid Ltd
PYPD
4
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is PolyPid Ltd's price target?
Analysts forecast that PolyPid Ltd's price target is USD 13.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 10.00.
How have PolyPid LtdPYPD's recent earnings per share performed?
The market expectation was USD -0.35, while PolyPid LtdPYPD's earnings per share (EPS) for the previous quarter was USD -0.41. EPS for the next quarter is expected at USD -0.37.
What is the analyst rating for PolyPid Ltd?
Based on the ratings of PolyPid Ltd's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.